Present your company at BIO-Europe Spring
Showcase your innovations to an audience of top-tier investors, biopharma execs and potential partners at BIO-Europe Spring and tap into the funding to drive your business forward.
Priority Review Deadline to Apply: November 22, 2024
Companies that submit applications by November 22 will be notified about the status of their application on December 11, 2024.
Priority review deadlines
Submit your application to present before November 22, 2024, to be involved in the first review round and receive a notification about your application before the holidays!
Need more time? The deadline to apply for the second review round is January 20, 2025.
Round 1 | Deadline: November 22, 2024
Round 2 | Deadline: January 20, 2025
PRESENTATION OPTIONS
Whether you represent a pharma company or an academic innovator, BIO-Europe Spring offers a company presentation option for all companies—both in-person and digitally.
All-Access Presentation
A small group of companies will be selected to present onsite at the event. Please submit your application today to be considered for an in-person presentation.
Benefits of an all-access presentation:
- Increased visibility. Showcase your breakthroughs with a presentation timeslot onsite at BIO-Europe Spring.
- Generate interest. Raise your company’s profile and get in front of BD executives, top-tier VCs, pharma and private equity investors.
An In-person Company Presentation Includes:
- A presentation slot during BIO-Europe Spring, March 17-19, 2025
- Your pre-recorded presentation added to your partnering profile six weeks before the event for on-demand viewing by registered attendees.
Fee structure
- Biotech and Midsize Pharma
- EUR 1,250
- Academic Innovator and Next Generation
- EUR 715
Digital Presentation
Gain weeks of exposure and book more one-to-one meetings with a digital presentation.
Benefits of a digital presentation:
- Increased exposure. Your virtual presentation can be viewed on-demand by attendees up to six weeks prior to the event, and throughout the conference.
- More one-to-one meetings. Your virtual presentation in partnering ONE® will include a link for attendees to schedule one-to-one meetings with your company. Based on data from previous EBD events, presenting companies receive up to 25% more meeting requests.
- Targeted exposure. Digital presentations will be featured for a certain amount of time in partneringONE® and on an event digest email to registered attendees.
A Digital Company Presentation Includes:
- Your pre-recorded presentation added to your partnering profile six weeks before the event for on-demand viewing by registered attendees.
- Your one minute pre-recorded elevator pitch streamed onsite during BIO-Europe Spring, March 17 - 19, 2025
Fee Structure
- Biotech and Midsize Pharma
- EUR 900
- Academic Innovator and Next Generation
- EUR 365
PRESENTATION TRACKS
Biotech Company Presentations
In this track, biotech companies can seek partnership for their products, initiate strategic alliances and tap into the global financing network.
Next Generation Presentations
This track is the most direct way for early stage projects and small entrepreneurial companies to get their innovative asset or idea directly in front of potential partners.
Companies to be considered for Next Generation Presentation need to meet the following criteria:
- Created in the past three years
- Fewer than 20 employees
- Developing new therapeutic products or offering an innovative service
Academic Innovators Presentations
Academic researchers and technology transfer offices can apply to present their asset or idea to funding and development partners.
For more information, contact:
Olivia Guiliana
EBD Group
oguiliana@ebdgroup.com
Click here for information on cancellation policy, payments, and sending a replacement.